Alliancebernstein L.P. Cv Rx, Inc. Transaction History
Alliancebernstein L.P.
- $300 Billion
- Q3 2025
A detailed history of Alliancebernstein L.P. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 17,560 shares of CVRX stock, worth $159,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,560
Previous 15,860
10.72%
Holding current value
$159,796
Previous $93,000
47.31%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
14.2MCall Options Held
59.5KPut Options Held
30.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$37.3 Million7.51% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$18.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$9.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.97 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL696KShares$6.34 Million0.01% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $187M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...